Cargando…
Comparison of Oral versus Intravenous Proton Pump Inhibitors in Preventing Re-bleeding from Peptic Ulcer after Successful Endoscopic Therapy
BACKGROUND Proton pump inhibitors (PPIs) are now widely prescribed for the management of patients with acute upper gastrointestinal bleeding; although its optimal dose and route of administration has remained a controversial issue. The aim of this study was to assess the clinical effectiveness of hi...
Autores principales: | Valizadeh Toosi, Seyed Mohammad, Elahi Vahed, Ahmad Reza, Maleki, Iradj, Bari, Zohreh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Association of Gastroerterology and Hepatology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488504/ https://www.ncbi.nlm.nih.gov/pubmed/31049171 http://dx.doi.org/10.15171/mejdd.2018.116 |
Ejemplares similares
-
Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy
por: Yen, Hsu-Heng, et al.
Publicado: (2012) -
Comparison of Oral versus Intravenous Proton Pump Inhibitors in Preventing Re-bleeding from Peptic Ulcer after Successful Endoscopic Therapy
por: Karim, Rashid, et al.
Publicado: (2020) -
Retraction: Comparison of Oral versus Intravenous Proton Pump Inhibitors in Preventing Re-bleeding from Peptic Ulcer after Successful Endoscopic Therapy
por: Karim, Rashid, et al.
Publicado: (2021) -
High or Nonhigh Doses of Proton Pump Inhibitors for Patients with Peptic Ulcer Bleeding?
por: Hsieh, Yu-Hsi, et al.
Publicado: (2013) -
Endoscopic Obliteration for Bleeding Peptic Ulcer
por: Włodarczyk, A. W., et al.
Publicado: (1997)